Martin A Weinstock1,2, Laura K Ferris3, Melissa I Saul4, Alan C Geller5, Patricia M Risica6, Julia A Siegel7, Francis X Solano8, John M Kirkwood9. 1. Center for Dermatoepidemiology, Providence VA Medical Center, Providence, Rhode Island. maw@brown.edu. 2. Departments of Dermatology and Epidemiology, Brown University, Providence, Rhode Island. maw@brown.edu. 3. Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania. 5. Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts. 6. Department of Epidemiology, Brown University, Providence, Rhode Island. 7. Center for Dermatoepidemiology, Providence VA Medical Center, Providence, Rhode Island. 8. Physician Services Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 9. Melanoma and Skin Cancer Program, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Population-based screening for the early detection of melanoma holds great promise for reducing melanoma mortality, but evidence is needed to determine whether benefits outweigh risks. Skin surgeries and dermatology visits after screening were assessed to indicate potential physical, psychological, and financial consequences. METHODS: Targeted primary care providers (PCPs) at the University of Pittsburgh Medical Center were trained to detect early melanoma using the INFORMED (INternet course FOR Melanoma Early Detection) program. The authors analyzed aggregated administrative data describing 3 groups of patients aged ≥35 years who had received an annual physical examination by PCPs: group A1 included patients of PCPs from the group with the highest percentage of INFORMED-trained providers, group A2 included patients of PCPs from the group with a lower percentage of INFORMED-trained providers, and group B included patients of PCPs without INFORMED training. RESULTS: INFORMED-trained PCPs screened 1572 of 16,472 patients in groups A1 or A2 and none of the 56,261 patients in group B. In group A1, there was a 79% increase (95% confidence interval, 15%-138%) in melanoma diagnoses noted; no increase was observed for the other groups, and no substantial increase in skin surgeries or dermatology visits occurred in any group. CONCLUSIONS: A large-scale melanoma screening using the INFORMED program was conducted in Pennsylvania. To the best of the authors' knowledge, the current study is the first analysis of downstream results and the findings indicate increased melanoma diagnoses but little impact on skin surgeries or dermatology visits. This result provides some reassurance that such efforts can be conducted without major adverse consequences, at least as measured by these parameters, and therefore should be considered for more widespread use. Cancer 2016;122:3152-6.
BACKGROUND: Population-based screening for the early detection of melanoma holds great promise for reducing melanoma mortality, but evidence is needed to determine whether benefits outweigh risks. Skin surgeries and dermatology visits after screening were assessed to indicate potential physical, psychological, and financial consequences. METHODS: Targeted primary care providers (PCPs) at the University of Pittsburgh Medical Center were trained to detect early melanoma using the INFORMED (INternet course FOR Melanoma Early Detection) program. The authors analyzed aggregated administrative data describing 3 groups of patients aged ≥35 years who had received an annual physical examination by PCPs: group A1 included patients of PCPs from the group with the highest percentage of INFORMED-trained providers, group A2 included patients of PCPs from the group with a lower percentage of INFORMED-trained providers, and group B included patients of PCPs without INFORMED training. RESULTS: INFORMED-trained PCPs screened 1572 of 16,472 patients in groups A1 or A2 and none of the 56,261 patients in group B. In group A1, there was a 79% increase (95% confidence interval, 15%-138%) in melanoma diagnoses noted; no increase was observed for the other groups, and no substantial increase in skin surgeries or dermatology visits occurred in any group. CONCLUSIONS: A large-scale melanoma screening using the INFORMED program was conducted in Pennsylvania. To the best of the authors' knowledge, the current study is the first analysis of downstream results and the findings indicate increased melanoma diagnoses but little impact on skin surgeries or dermatology visits. This result provides some reassurance that such efforts can be conducted without major adverse consequences, at least as measured by these parameters, and therefore should be considered for more widespread use. Cancer 2016;122:3152-6.
Authors: Waqas R Shaikh; Alan Geller; Gwen Alexander; Maryam M Asgari; Gunther J Chanange; Stephen Dusza; Melody J Eide; Suzanne W Fletcher; Jacqueline M Goulart; Allan C Halpern; Shoshana Landow; Ashfaq A Marghoob; Elizabeth A Quigley; Martin A Weinstock Journal: J Cancer Educ Date: 2012-12 Impact factor: 2.037
Authors: Melody J Eide; Maryam M Asgari; Suzanne W Fletcher; Alan C Geller; Allan C Halpern; Waqas R Shaikh; Lingling Li; Gwen L Alexander; Andrea Altschuler; Stephen W Dusza; Ashfaq A Marghoob; Elizabeth A Quigley; Martin A Weinstock Journal: J Am Board Fam Med Date: 2013 Nov-Dec Impact factor: 2.657
Authors: Alexander Katalinic; Annika Waldmann; Martin A Weinstock; Alan C Geller; Nora Eisemann; Ruediger Greinert; Beate Volkmer; Eckhard Breitbart Journal: Cancer Date: 2012-04-19 Impact factor: 6.860
Authors: Martin A Weinstock; Patricia M Risica; Rosemarie A Martin; William Rakowski; Catherine Dubé; Marianne Berwick; Michael G Goldstein; Suddhasatta Acharyya; Thomas Lasater Journal: Am J Prev Med Date: 2007-06 Impact factor: 5.043
Authors: June K Robinson; Namita Jain; Ashfaq A Marghoob; William McGaghie; Michael MacLean; Pedram Gerami; Brittney Hultgren; Rob Turrisi; Kimberly Mallett; Gary J Martin Journal: J Gen Intern Med Date: 2018-02-05 Impact factor: 5.128
Authors: Richard A Shellenberger; Karine Tawagi; Sweta Kakaraparthi; Jeremy Albright; Mohammed Nabhan; Alan C Geller Journal: J Gen Intern Med Date: 2018-11 Impact factor: 5.128
Authors: Susan M Swetter; Julia Chang; Amanda R Shaub; Martin A Weinstock; Eleanor T Lewis; Steven M Asch Journal: JAMA Dermatol Date: 2017-08-01 Impact factor: 10.282
Authors: Ashley E Brown; Maleka Najmi; Taylor Duke; Daniel A Grabell; Misha V Koshelev; Kelly C Nelson Journal: J Gen Intern Med Date: 2022-06-16 Impact factor: 6.473
Authors: Shirin Bajaj; Zachary J Wolner; Stephen W Dusza; Ralph P Braun; Ashfaq A Marghoob; Jennifer DeFazio Journal: Dermatol Pract Concept Date: 2019-04-30
Authors: Laura K Ferris; Melissa I Saul; Yan Lin; Fei Ding; Martin A Weinstock; Alan C Geller; Jian-Min Yuan; Erica Neuren; Spandana Maddukuri; Francis X Solano; John M Kirkwood Journal: JAMA Oncol Date: 2017-08-01 Impact factor: 31.777
Authors: Wayne A Warner; Vandana Devika Sookdeo; Srikanth Umakanthan; Kevin Sarran; Lemuel Pran; Maurice Fortuné; Wesley Greaves; Sharda Narinesingh; Dave Harnanan; Ravi Maharaj Journal: Int J Surg Case Rep Date: 2016-11-27
Authors: Patricia Markham Risica; Natalie H Matthews; Laura Dionne; Jennifer Mello; Laura K Ferris; Melissa Saul; Alan C Geller; Francis Solano; John M Kirkwood; Martin A Weinstock Journal: Prev Med Rep Date: 2018-04-17